Paper39882178
Efficacy and Safety of a Novel Low-Dose Water-Dispersible Turmeric Extract in the Management of Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Thanawala S and 5 others. J Pain Res, 2025. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Efficacy and Safety of a Novel Low-Dose Water-Dispersible Turmeric Extract in the Management of Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Papers, record 39882178. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39882178
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Efficacy and Safety of a Novel Low-Dose Water-Dispersible Turmeric Extract in the Management of Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28430129 | Curcumin Inhibits Apoptosis of Chondrocytes through Activation ERK1/2 Signaling Pathways Induced Autophagy. | Nutrients | 2017 | https://conductscience.org/library/papers/28430129 | PubMed |
| 2 | 27761693 | Curcuma longa extract reduces inflammatory and oxidative stress biomarkers in osteoarthritis of knee: a four-month, double-blind, randomized, placebo-controlled trial. | Inflammopharmacology | 2016 | https://conductscience.org/library/papers/27761693 | PubMed |
| 3 | 33207632 | Pathophysiological Perspective of Osteoarthritis. | Medicina (Kaunas) | 2020 | https://conductscience.org/library/papers/33207632 | PubMed |
| 4 | 35935936 | Efficacy and Safety of Curcumin and Curcuma longa Extract in the Treatment of Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trial. | Front Immunol | 2022 | https://conductscience.org/library/papers/35935936 | PubMed |
| 5 | 33516238 | Bioavailable turmeric extract for knee osteoarthritis: a randomized, non-inferiority trial versus paracetamol. | Trials | 2021 | https://conductscience.org/library/papers/33516238 | PubMed |
| 6 | 14613558 | The Knee injury and Osteoarthritis Outcome Score (KOOS): from joint injury to osteoarthritis. | Health Qual Life Outcomes | 2003 | https://conductscience.org/library/papers/14613558 | PubMed |
| 7 | 34754179 | Anti-Inflammatory Effects of Curcumin in the Inflammatory Diseases: Status, Limitations and Countermeasures. | Drug Des Devel Ther | 2021 | https://conductscience.org/library/papers/34754179 | PubMed |
| 8 | 32064134 | Highly bioavailable curcumin powder suppresses articular cartilage damage in rats with mono-iodoacetate (MIA)-induced osteoarthritis. | Food Sci Biotechnol | 2020 | https://conductscience.org/library/papers/32064134 | PubMed |
| 9 | 22122768 | Curcumin: the potential for efficacy in gastrointestinal diseases. | Best Pract Res Clin Gastroenterol | 2011 | https://conductscience.org/library/papers/22122768 | PubMed |
| 10 | 33041781 | Turmeric and Its Major Compound Curcumin on Health: Bioactive Effects and Safety Profiles for Food, Pharmaceutical, Biotechnological and Medicinal Applications. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/33041781 | PubMed |
| 11 | 10489324 | Clinically relevant change and clinically relevant difference in knee osteoarthritis. | Osteoarthritis Cartilage | 1999 | https://conductscience.org/library/papers/10489324 | PubMed |
| 12 | 37294813 | Impact of end-stage knee osteoarthritis on perceived physical function and quality of life: A descriptive study from Jordan. | PLoS One | 2023 | https://conductscience.org/library/papers/37294813 | PubMed |
| 13 | 31351488 | Bio-optimized Curcuma longa extract is efficient on knee osteoarthritis pain: a double-blind multicenter randomized placebo controlled three-arm study. | Arthritis Res Ther | 2019 | https://conductscience.org/library/papers/31351488 | PubMed |
| 14 | 25442263 | Synergistic effect of the interaction between curcumin and diclofenac on the formalin test in rats. | Phytomedicine | 2014 | https://conductscience.org/library/papers/25442263 | PubMed |
| 15 | 29018060 | Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis. | Br J Sports Med | 2018 | https://conductscience.org/library/papers/29018060 | PubMed |
| 16 | 20816981 | Circulating levels of IL-6 and TNF-α are associated with knee radiographic osteoarthritis and knee cartilage loss in older adults. | Osteoarthritis Cartilage | 2010 | https://conductscience.org/library/papers/20816981 | PubMed |
| 17 | 24672232 | Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis: a multicenter study. | Clin Interv Aging | 2014 | https://conductscience.org/library/papers/24672232 | PubMed |
| 18 | 34325496 | Sample size determination and power analysis using the G*Power software. | J Educ Eval Health Prof | 2021 | https://conductscience.org/library/papers/34325496 | PubMed |
| 19 | 29731662 | Test-retest reliability, validity, and minimum detectable change of visual analog, numerical rating, and verbal rating scales for measurement of osteoarthritic knee pain. | J Pain Res | 2018 | https://conductscience.org/library/papers/29731662 | PubMed |
| 20 | 38036015 | Efficacy and safety of curcumin therapy for knee osteoarthritis: A Bayesian network meta-analysis. | J Ethnopharmacol | 2024 | https://conductscience.org/library/papers/38036015 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42075010 | Turmeric: A Comprehensive Review of Its Botany, Traditional Uses, Phytochemistry, and Mechanisms as a Functional Food. | Nutrients | 2026 | https://conductscience.org/library/papers/42075010 | PubMed |
| 41737916 | A randomized, double-blind, controlled study on the efficacy of an oral dietary supplement containing fish oil, ASU and phytotherapeutic extracts in canine osteoarthritis. | Front Vet Sci | 2025 | https://conductscience.org/library/papers/41737916 | PubMed |
| 40971325 | Efficacy and Safety of an Oral Low-Dose Water-Dispersible Turmeric Extract Capsule on Facial Skin Health in Healthy Women: A Randomized, Double-Blind, Placebo-Controlled Trial. | J Cosmet Dermatol | 2025 | https://conductscience.org/library/papers/40971325 | PubMed |
| 40615851 | Effects of curcumin on serum inflammatory biomarkers in patients with knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. | BMC Complement Med Ther | 2025 | https://conductscience.org/library/papers/40615851 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IL1B | 3553 | PubTator's text mining | https://conductscience.org/library/genes/3553 | NCBI Gene |
| IL6 | 3569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39882178
GET https://conductscience.org/api/papers/v1/39882178/references?page=2